Skip to main content

Advertisement

Log in

Neutralization assay to resolve discrepancies between positive results in new highly sensitive anti-Toxoplasma gondii IgG assays and negative results in reference tests

  • Brief Report
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

High sensitivity of IgG assays is required in order to diagnose Toxoplasma infection in immunocompromised patients and women before and during early pregnancy. Positive results obtained in new highly sensitive Toxoplasma IgG assays have been observed in sera that gave negative results in reference assays. To allow the resolution of these discrepancies, we developed a neutralization assay using 80 µg/ml of a soluble membrane fraction of Toxoplasma in the automated Elecsys IgG assay. We were able to block the detection of Toxoplasma IgG antibodies in 283 sera with IgG titers ranging from below the limit of detection to >2,300 IU/ml. The mean percentage of neutralization was 88%, with a minimum neutralization of 77%. In summary, the neutralization assay represents a valuable tool to confirm the specificity of Toxoplasma IgG antibodies in the sera of immunocompromised patients and women before and during early pregnancy. Discrepancies between positive results in highly sensitive Toxoplasma IgG assays and negative results in reference assays can, thereby, be resolved and may allow a decision to be made on the management of patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Montoya JG (2002) Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis. J Infect Dis 185(Suppl 1):S73–S82

    Article  PubMed  Google Scholar 

  2. Montoya JG, Liesenfeld O (2004) Toxoplasmosis. Lancet 363(9425):1965–1976

    Article  CAS  PubMed  Google Scholar 

  3. Smego RA Jr, Orlovic D, Wadula J (2006) An algorithmic approach to intracranial mass lesions in HIV/AIDS. Int J STD AIDS 17(4):271–276

    Article  PubMed  Google Scholar 

  4. Elbez-Rubinstein A, Ajzenberg D, Dardé ML, Cohen R, Dumètre A, Yera H, Gondon E, Janaud JC, Thulliez P (2009) Congenital toxoplasmosis and reinfection during pregnancy: case report, strain characterization, experimental model of reinfection, and review. J Infect Dis 199(2):280–285

    Article  PubMed  Google Scholar 

  5. Coombs RW, Collier AC, Allain JP, Nikora B, Leuther M, Gjerset GF, Corey L (1989) Plasma viremia in human immunodeficiency virus infection. N Engl J Med 321(24):1626–1631

    Article  CAS  PubMed  Google Scholar 

  6. Centers for Disease Control and Prevention (CDC) (2005) Guidelines for viral hepatitis surveillance and case management. CDC, Atlanta, GA. Available online at: http://www.cdc.gov/Hepatitis/SurveillanceGuidelines.htm

Download references

Acknowledgments

We cordially thank B. Andres and M. Eibl for their excellent technical assistance and M. Symannek for providing the Toxoplasma antigen and cell extracts. We thank Ph. Thuillez (Institut de Puériculture et de Périnatalogie, Paris, France) for performing the Sabin-Feldman Dye test and the direct agglutination assay.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D. Rößler.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Köhler, S., Rößler, D., Hornauer, S. et al. Neutralization assay to resolve discrepancies between positive results in new highly sensitive anti-Toxoplasma gondii IgG assays and negative results in reference tests. Eur J Clin Microbiol Infect Dis 29, 359–363 (2010). https://doi.org/10.1007/s10096-009-0864-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-009-0864-8

Keywords

Navigation